Epstein Secrets

Chiacu, Lewis), the Washington Times <https://www.washingtontimes.com/news/2020/nov/12/joe-biden-should-start-getting-access-intel-senate/> (11/12, Sherfinski, Meier, 492K), and NPR <https://www.npr.org/sectionillive-updates-2020-election- results/2020/11/12/934269681/senate-republicans-back-push-for-presid

ters <https://www.reuters.corn/article/us-health-coronavirus-fatality/covid-19-fatality-rate-down-30-since- april-study-finds-idUSICBN27S39D> (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

s Rose 79% In July. The Washington Times <https://www.washingtontimes.com/news/2020/aug/3/gun-background-checks-jump-79- july-amid-coronaviruk (8/3, Sherfinski, 492K) reports gun background checks "surged 79% in July compared to last year amid national unrest, protests and rioting, according to data release

s://www.reuters.com/article/us-health-coronavirus-treatments-antibod/next-big-covid-19-treatment-may-be- manufactured-antibodies-idUSKBN2421DY> (8/3, Beasley) reports, "As the world awaits a COVID-I9 vaccine, the next big advance in battling the pandemic could come from...antibodies designed specifically

h 'respect for Constitutionally protected free speech and political activities." Bloomberg (1/22, Sink, Parker, 3.57M), the Washington Times (1/22, Sherfinski, 626K), Business Insider (1/24, Al-Arshani, 2.74M), Fox News (1/22, Singman, 23.99M), NBC News (1/22, Dilanian, 4.91M), and NPR (1/22, Lucas, 3.69M

break from Trump's discursive approach to the pandemic as cases continue to climb nationwide." USA Today (1/24, Rivera, 12.7M) and Politico (1/24, Beasley, 6.73M) also report. US Passes 25M Confirmed Cases; Epidemiologist Pegs Total At More Than 105M. The AP (1/24) says "the new milestone" of 25 milli

ription Publication, 7.57M), Bloomberg (11/12, Dennis, 4.73M), EFTA00148405 Reuters (11/12, Cornwell, Chiacu, Lewis), the Washington Times (11/12, Sherfinski, Meier, 492K), and NPR (11/12, Grisales, 3.12M), among others. Meanwhile, according to the New York Times (11/12, Sanger, Stevens, Perlroth, 18.61M

eatments and the increased share of cases among young people, who are more likely than older ones to survive a bout with COVID-19." Reuters (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

on, Wise, Subscription Publication, 7.57M), Bloomberg (11/12, Dennis, 4.73M), Reuters (11/12, Cornwell, Chiacu, Lewis), the Washington Times (11/12, Sherfinski, Meier, 492K), and NPR (11/12, Grisales, 3.12M), among others. Meanwhile, according to the New York Times (11/12, Sanger, Stevens, Perlroth, 18.61M

eatments and the increased share of cases among young people, who are more likely than older ones to survive a bout with COVID-19." Reuters (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

uld not have been used to diagnose or rule out an active COVID-19 infection?" Gun Background Checks Rose 790/0 In July. The Washington Times (8/3, Sherfinski, 492K) reports gun background checks "surged 79% in July compared to last year amid national unrest, protests and rioting, according to data releas

RN- TVVi Nashville, TN (8/3, 24K), and WXIA-TVVI Atlanta (8/3, 100K). Monoclonal Antibodies Could Be "Next Big Advance" In Treatment. Reuters (8/3, Beasley) reports, "As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from...antibodies designed specifically

ould not have been used to diagnose or rule out an active COVID-19 infection.'" Gun Background Checks Rose 79% In July. The Washington Times (8/3, Sherfinski, 492K) reports gun background checks "surged 79% in July compared to last year amid national unrest, protests and rioting, according to data releas

RN- TVVi Nashville, TN (8/3, 24K), and WXIA-TVVI Atlanta (8/3, 100K). Monoclonal Antibodies Could Be "Next Big Advance" In Treatment. Reuters (8/3, Beasley) reports, "As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from...antibodies designed specifically